合并肝脓肿的肝内胆管细胞癌1例
A Case of Intrahepatic Cholangiocarcinoma Combined with Liver Abscess
DOI: 10.12677/acm.2024.1451670, PDF,    国家自然科学基金支持
作者: 郑 炜, 王粤培, 梁楚琳, 黄国庆, 刘序友*：广州红十字会医院消化内科，广东 广州
关键词: 肝内胆管细胞癌；肝脓肿；华支睾吸虫病；病例报告；Intrahepatic Cholangiocarcinoma； Liver Abscess； Clonorchiasis； Casereport
摘要: 肝内胆管细胞癌在临床上发病率较低，因其发病隐匿、症状不典型，临床误诊、漏诊率较高，现报道1例合并肝脓肿的肝内胆管细胞癌的诊治过程，通过文献复习回顾了该病的临床表现、流行现状及诊治要点，以提高临床医师对该病的认识，做到早诊早治。
Abstract: The incidence rate of intrahepatic cholangiocarcinoma is relatively low in clinical work, and because of its insidious onset and atypical symptoms, the rate of misdiagnosis and underdiagnosis is high. This study reported the diagnostic and treatment process of a case of intrahepatic cholangiocarcinoma combined with liver abscess. Through literature review, the clinical manifestations and treatment points of the disease were reviewed. In order to improve clinicians’ understanding of the diagnosis and treatment of intrahepatic cholangiocarcinoma and implement early diagnosis and treatment.
文章引用：郑炜, 王粤培, 梁楚琳, 黄国庆, 刘序友. 合并肝脓肿的肝内胆管细胞癌1例[J]. 临床医学进展, 2024, 14(5): 2200-2205. https://doi.org/10.12677/acm.2024.1451670

参考文献

[1] Khan, S.A., Tavolari, S. and Brandi, G. (2019) Cholangiocarcinoma: Epidemiology and Risk Factors. Liver International, 39, 19-31. [Google Scholar] [CrossRef] [PubMed]
[2] Sirica, A.E., Gores, G.J., Groopman, J.D., et al. (2019) Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances. Hepatology, 69, 1803-1815. [Google Scholar] [CrossRef] [PubMed]
[3] European Association for the Study of the Liver (2023) EASL-ILCA Clinical Practice Guidelines on the Management of Intrahepatic Cholangiocarcinoma. Journal of Hepatology, 79, 181-208. [Google Scholar] [CrossRef] [PubMed]
[4] Sarcognato, S., Sacchi, D., Fassan, M., et al. (2021) Cholangiocarcinoma. Pathologica, 113, 158-169. [Google Scholar] [CrossRef] 
[5] 陈颖丹, 周长海, 朱慧慧, 等. 2015年全国人体重点寄生虫病现状调查分析[J]. 中国寄生虫学与寄生虫病杂志, 2020, 38(1): 5-16.
[6] Qian, M.B., Chen, Y.D., Fang, Y.Y., et al. (2011) Disability Weight of Clonorchis Sinensis Infection: Captured from Community Study and Model Simulation. PLOS Neglected Tropical Diseases, 5, e1377. [Google Scholar] [CrossRef] [PubMed]
[7] Sripa, B., Brindley, P.J., Mulvenna, J., et al. (2012) The Tumorigenic Liver Fluke Opisthorchis Viverrini—Multiple Pathways to Cancer. Trends in Parasitology, 28, 395-407. [Google Scholar] [CrossRef] [PubMed]
[8] Yacoub, H., Hassine, H., Boukriba, S., et al. (2020) Intrahepatic Cholangiocarcinoma Mimicking a Liver Abscess. Clinical Case Reports, 8, 2510-2513. [Google Scholar] [CrossRef] [PubMed]
[9] Capuozzo, M., Santorsola, M., Ferrara, F., et al. (2024) Intrahepatic Cholangiocarcinoma Biomarkers: Towards Early Detection and Personalized Pharmacological Treatments. Molecular and Cellular Probes, 73, Article 101951. [Google Scholar] [CrossRef] [PubMed]
[10] Oliveira, I.S., Kilcoyne, A., Everett, J.M., et al. (2017) Cholangiocarcinoma: Classification, Diagnosis, Staging, Imaging Features, and Management. Abdominal Radiology, 42, 1637-1649. [Google Scholar] [CrossRef] [PubMed]
[11] Xing, L.H., Zhuo, L.Y., Zhang, Y., et al. (2022) DWI Combined with Hepatobiliary-Phase Enhanced Imaging Can Better Differentiate Cholangiocarcinoma from Atypical Liver Abscesses. Frontiers in Oncology, 12, Article 723089. [Google Scholar] [CrossRef] [PubMed]
[12] Lo, E.C., Rucker, A.N. and Federle, M.P. (2018) Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Imaging for Diagnosis, Tumor Response to Treatment and Liver Response to Radiation. Seminars in Radiation Oncology, 28, 267-276. [Google Scholar] [CrossRef] [PubMed]
[13] Mosele, F., Remon, J., Mateo, J., et al. (2020) Recommendations for the Use of Next-Generation Sequencing (NGS) for Patients with Metastatic Cancers: A Report from the ESMO Precision Medicine Working Group. Annals of Oncology, 31, 1491-1505. [Google Scholar] [CrossRef] [PubMed]
[14] Verdaguer, H., Saurí, T., Acosta, D.A., et al. (2022) ESMO Scale for Clinical Actionability of Molecular Targets Driving Targeted Treatment in Patients with Cholangiocarcinoma. Clinical Cancer Research, 28, 1662-1671. [Google Scholar] [CrossRef] 
[15] Benson, A.B., d’Angelica, M.I., Abbott, D.E., et al. (2021) Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 19, 541-565. [Google Scholar] [CrossRef] [PubMed]
[16] Li, C., Li, G., Miao, R., et al. (2012) Primary Liver Cancer Presenting as Pyogenic Liver Abscess: Characteristics, Diagnosis, and Management. Journal of Surgical Oncology, 105, 687-691. [Google Scholar] [CrossRef] [PubMed]
[17] Bridgewater, J., Galle, P.R., Khan, S.A., et al. (2014) Guidelines for the Diagnosis and Management of Intrahepatic Cholangiocarcinoma. Journal of Hepatology, 60, 1268-1289. [Google Scholar] [CrossRef] [PubMed]
[18] Li, W.Z. and Huang, J.A. (2021) Advances in the Study of Occult Malignant Tumor-Related Pyogenic Liver Abscesses in the Digestive System. Chinese Journal of Hepatology, 29, 275-278.
[19] Giuliani, A., Caporale, A., Demoro, M., et al. (2007) Silent Colon Carcinoma Presenting as a Hepatic Abscess. Tumori Journal, 93, 616-618. [Google Scholar] [CrossRef] [PubMed]
[20] Lee, S.H., Kim, K.A., Lee, J.S., et al. (2006) A Case of Primary Neuroendocrine Carcinoma of Liver Presenting with Liver Abscess. The Korean Journal of Gastroenterology, 48, 277-280.
[21] Shah, V., Arora, A., Tyagi, P., et al. (2015) Intrahepatic Cholangiocarcinoma Masquerading as Liver Abscess. Journal of Clinical and Experimental Hepatology, 5, 89-92. [Google Scholar] [CrossRef] [PubMed]
[22] Ham, H., Kim, H.Y., Seo, K.J., et al. (2015) Cholangiocarcinoma with a Paraneoplastic Leukemoid Reaction Mimicking a Pyogenic Liver Abscess. The Korean Journal of Internal Medicine, 30, 110-113. [Google Scholar] [CrossRef] [PubMed]

为你推荐